HomeInsightsMarket Capitalization

Market Capitalization of Concord Drugs Ltd

Market Capitalization of Concord Drugs Ltd

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

5.0 K

stocks traded

Last Updated time: 05 Nov 9.00 AM

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

MARKETCAP

37.75 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Concord Drugs Ltd is ₹ 37.75 crore as of 04 Nov 24.
  • The Market Cap of Concord Drugs Ltd changed from ₹ 25.36 crore on March 2022 to ₹ 35.17 crore on March 2024 . This represents a CAGR of 11.52% over 3 years. .
  • The Latest Trading Price of Concord Drugs Ltd is ₹ 37.75 as of 04 Nov 15:30.

Historical Market Cap of Concord Drugs Ltd

No data available

* All values are in crore

Company Fundamentals for Concord Drugs Ltd

No data available

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

PRICE

37.75

-0.25 (-0.66%)

stock direction

Last updated on: Nov 04 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 202437.75
01 Nov 202438
31 Oct 202437.61
30 Oct 202437.02
29 Oct 202436.21
28 Oct 202435.64
25 Oct 202433.74
24 Oct 202436
23 Oct 202435.36
22 Oct 202436.3

BlinkX Score for Concord Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Concord Drugs Ltd

No data available

Historical P/E Ratio of Concord Drugs Ltd

No data available

* All values are in %

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Concord Drugs Ltd

No data available

* All values are in %

About Concord Drugs Ltd

  • Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
  • The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
  • State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

Concord Drugs Ltd News Hub

News

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 202417:57

News

Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 202410:06

News

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September ...

Read more

03 Sep 202411:10

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 202...

Read more

06 Aug 202416:20

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

25 May 202411:26

News

Concord Drugs declare Quarterly Result

Concord Drugs will hold a meeting of the Board of Directors of the Company on 25 May 2024 ...

Read more

16 May 202412:41

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Concord Drugs Ltd Market Cap

What is the market cap of Concord Drugs Ltd?

As of November 5, 2024, Concord Drugs Ltd has a market capitalization of ₹37.75, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Concord Drugs Ltd's market capitalization?

Concord Drugs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Concord Drugs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Concord Drugs Ltd's market capitalization change?

Concord Drugs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*